This outcome has been attributed largely to reduced tumor infiltration by myeloid cells and repolarization of MDSC toward an immunostimulatory phenotype, which was accompanied by elevated anti-tumor CD4+ and CD8+ T cell responses. The gene discussed is CD4; the disease is neoplasm.